Cargando…
Targeting Pyruvate Carboxylase by a Small Molecule Suppresses Breast Cancer Progression
Rapid metabolism differentiates cancer cells from normal cells and relies on anaplerotic pathways. However, the mechanisms of anaplerosis‐associated enzymes are rarely understood. The lack of potent and selective antimetabolism drugs restrains further clinical investigations. A small molecule ZY‐444...
Autores principales: | Lin, Qingxiang, He, Yuan, Wang, Xue, Zhang, Yong, Hu, Meichun, Guo, Weikai, He, Yundong, Zhang, Tao, Lai, Li, Sun, Zhenliang, Yi, Zhengfang, Liu, Mingyao, Chen, Yihua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201266/ https://www.ncbi.nlm.nih.gov/pubmed/32382484 http://dx.doi.org/10.1002/advs.201903483 |
Ejemplares similares
-
Pyruvate carboxylase and cancer progression
por: Kiesel, Violet A., et al.
Publicado: (2021) -
A potent and selective small molecule inhibitor of myoferlin attenuates colorectal cancer progression
por: He, Yuan, et al.
Publicado: (2021) -
A small molecule targeting myoferlin exerts promising anti-tumor effects on breast cancer
por: Zhang, Tao, et al.
Publicado: (2018) -
A Unique Case of Pyruvate Carboxylase Deficiency
por: Hidalgo, Jessica, et al.
Publicado: (2021) -
A novel synthetic small molecule YH-306 suppresses colorectal tumour growth and metastasis viaFAK pathway
por: Dai, Fujun, et al.
Publicado: (2015)